Norway vs Sweden: Cause of death, by non-communicable diseases, ages 0-4, male
Norway
46.6%
in 2021
Sweden
46.3%
in 2021
Norway rank
17th
Sweden rank
20th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Norway
- Sweden
How they compare
Norway currently reports 46.6% against 46.3% in Sweden, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Sweden ahead.
Norway ranks 17th and Sweden ranks 20th of 185 countries.
Across the 3 decades both report, Norway averaged higher in 2 and Sweden in 1.
Head to head by decade
| Decade | Norway | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.9% | 54.3% | 4.3% | Sweden |
| 2010s | 48.2% | 44.7% | 3.5% | Norway |
| 2020s | 45.8% | 45.6% | 0.2% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Norway or Sweden?
- Norway, at 46.6% against 46.3% in Sweden as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Norway and Sweden?
- 0.3%, with Norway ahead.
- How many years of comparable data are there for Norway and Sweden?
- 6 years are reported by both, from 2000 to 2021.
- How do Norway and Sweden rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Norway ranks 17th and Sweden ranks 20th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.